Olema Pharmaceuticals (OLMA) Stock Price & Analysis

OLMA$7.56+0.04 +0.53%
BiotechnologyGrowth Stock
Compare
Market cap$662.30MEnterprise value$624.75MRevenue (TTM)$0Market position—

Score

68
Bullish
Value
57
Quality
46
Growth
100

AI Analysis

Snapshot

Olema Pharmaceuticals is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 68/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~275% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

57
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

46
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Olema Pharmaceuticals, Inc. (OLMA) last printed $7.56. Equity value is $662.30M. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

20182019202020212022202320242025
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

About

Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER) antagonist and selective ER degrader, is presently undergoing Phase 1/2 clinical evaluations. This drug candidate is being assessed for its efficacy in managing recurrent, locally advanced, or metastatic breast cancer that expresses estrogen receptors but is negative for human epidermal growth factor receptor 2.

Olema Pharmaceuticals (OLMA) Stock Price & Analysis

OLMA price $7.56 +0.04 +0.53%

Ticker
OLMA
Price
$7.56
Change
+0.04 +0.53%
Market cap
$662.30M
Dividend yield
0.00%
Beta
2.02
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
57
Quality
46
Growth
100

Stocklytics score rationale: value 57, quality 46, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener